In this week’s video, Dr. Brian G.M. Durie explains the meaning of the term “risk,” as it relates to myeloma.

BOTTOM LINE: 

The use of the word “risk” in myeloma staging can be confusing.


Image of Dr. Brian G.M. DurieDr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.

Previous Post
BOCA PFS 2016: Managing Side Effects
Next Post
Is it reasonable to take Zometa for longer than two years?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.